rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Paul Lammers

Director

Company insider

Files Form 4 as: Director, Decoy Therapeutics; President & CEO, Synlogic; President, Repros Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
11
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
3
Companies where not an officer
1
First trade
18 Feb 2009
Last trade
31 Aug 2026
Last filed
2 Sep 2026

Companies traded

Where they are an officer
SynlogicDirector, Officer · Biotechnology · last 11 Mar 20160 buys · 0 sells
Repros TherapeuticsOfficer · last 18 Feb 20090 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
DCOY Decoy TherapeuticsDirector · Biotechnology · last 31 Aug 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
31 Aug 2026filed 2 Sep 2026DCOY Decoy TherapeuticsBiotechnologySEC FORM 4 Code A—2,000 at $0.00filing
31 Aug 2026filed 2 Sep 2026DCOY Decoy TherapeuticsBiotechnologySEC FORM 4 Code A—2,000 at $0.00filing
20 Feb 2024filed 22 Feb 2024DCOY Decoy Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—20,500 at $0.00filing
3 Jan 2023filed 5 Jan 2023DCOY Decoy TherapeuticsBiotechnologySEC FORM 4 Code A—1,440 at $0.00filing
20 Jan 2022filed 21 Jan 2022DCOY Decoy Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
2 Dec 2020filed 4 Dec 2020DCOY Decoy Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
23 Mar 2020filed 25 Mar 2020DCOY Decoy Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—6,000 at $0.00filing
10 Sep 2019filed 12 Sep 2019DCOY Decoy Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—3,000 at $0.00filing
11 Mar 2016filed 14 Mar 2016Synlogicoption or derivative · BiotechnologySEC FORM 4 Code A—165,000 at $0.00filing
30 Sep 2015filed 30 Sep 2015Synlogicoption or derivative · BiotechnologySEC FORM 4 Code A—76,666 at $0.00filing
18 Feb 2009filed 27 Feb 2009Repros Therapeuticsoption or derivativeSEC FORM 4 Code A—300,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

New Enterprise Associates 14, L.P.Director and 10% owner · Director and 10% owner at Synlogic, filing Form 4 there in the last year